Brazil nut (Bertholletia excelsa, H.B.K.) improves oxidative stress and inflammation biomarkers in hemodialysis patients

Biological Trace Element Research

Volumn 158, Issue 1, 2014, Pages 105-112

  Stockler Pinto, Milena Barcza ^a   Mafra, Denise ^b   Moraes, Cristiane ^b   Lobo, Julie ^c   Boaventura, Gilson Teles ^b   Farage, Najla Elias ^d   Silva, Wellington Seguins ^e   Cozzolino, Silvia Franciscato ^f   Malm, Olaf ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^c National Institute of Traumatology and Orthopedics INTO   (Brazil)

^d Renalcor Clinic   (Brazil)

^e INSTITUTO OSWALDO CRUZ   (Brazil)

^f UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chronic kidney disease; Hemodialysis; Oxidative stress and inflammation; Selenium

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; 8 ISOPROSTANE; BIOLOGICAL MARKER; CHOLESTEROL; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SELENIUM; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; 8-EPI-PROSTAGLANDIN F2ALPHA; 8-OXO-7-HYDRODEOXYGUANOSINE; CYTOKINE; DEOXYGUANOSINE; LIPID; PROSTAGLANDIN F2 ALPHA;

ADULT; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROGENESIS; BRAZIL; BRAZIL NUT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; DIET SUPPLEMENTATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; FOOD INTAKE; HEMODIALYSIS PATIENT; HUMAN; INFLAMMATION; MALE; OXIDATIVE STRESS; PROSTAGLANDIN BLOOD LEVEL; PROTEIN BLOOD LEVEL; RISK REDUCTION; SELENIUM BLOOD LEVEL; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; AGED; ANALOGS AND DERIVATIVES; BERTHOLLETIA; BLOOD; CHEMISTRY; CLINICAL TRIAL; DRUG EFFECTS; MIDDLE AGED; NUT; RENAL REPLACEMENT THERAPY; TIME; TREATMENT OUTCOME;

BERTHOLLETIA EXCELSA;

ADULT; AGED; BERTHOLLETIA; BIOLOGICAL MARKERS; CYTOKINES; DEOXYGUANOSINE; DIETARY SUPPLEMENTS; DINOPROST; GLUTATHIONE PEROXIDASE; HUMANS; INFLAMMATION; LIPIDS; MIDDLE AGED; NUTS; OXIDATIVE STRESS; RENAL DIALYSIS; SELENIUM; TIME FACTORS; TREATMENT OUTCOME;

EID: 84897084102     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-014-9904-z     Document Type: Article

References (44)

1. Ross R (1999) Atherosclerosis is an inflammatory disease. Am Heart J 5:419-420
2. Himmelfarb J, Stenvinkel P, Ikizler TA et al (2002) The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 62:1524-1538 (Pubitemid 35286260)
3. Kim HJ, Vaziri ND (2010) Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure. Am J Physiol Renal Physiol 298:662-671
4. Köken T, Serteser M, Kahraman A et al (2004) Changes in serum markers of oxidative stress with varying periods of haemodialysis. Nephrology 9:77-82 (Pubitemid 38530449)
5. Shad SV, Baliga R, Rajapurkar M et al (2007) Oxidants in chronic kidney disease. J Am Soc Nephrol 18:16-28 (Pubitemid 46053418)
6. Locatelli F, Canaud B, Eckardt KU et al (2003) Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant 18:1272-1280 (Pubitemid 36826946)
7. Zachara BA, Gromadzinska J, Wasowicz Wet al (2006) Red blood cell and plasma glutathione peroxidase activities and selenium concentration in patients with chronic kidney disease: a review. Acta Biochem Pol 53:663-677 (Pubitemid 46090116)
8. Wieczorowska-Tobis K, Wisniewska J, Korybalska K et al (2001) Plasma glutathione peroxidase activity in the elderly. Intern Urol Nephrol 32:463-467 (Pubitemid 32821215)
9. Santangelo F, Witko-Sarsat V, Drüeke T et al (2004) Restoring glutathione as a therapeutic strategy in chronic kidney disease. Nephrol Dial Transplant 19:1951-1955 (Pubitemid 39139622)
10. Margis R, Dunand C, Teixeira FK et al (2008) Glutathione peroxidase family-an evolution overview. FEBS J 275:3959-3970 (Pubitemid 351990959)
11. El-Far MA, Bakr MA, Farahat SE et al (2009) Glutathione peroxidase activity in patients with renal disorders. Clin Exp Nephrol 9: 127-131 (Pubitemid 40875101)
12. Rayman MP (2000) The importance of selenium to the human health. Lancet 356:233-241
13. Thomson CD (2004) Assessment of requirements for selenium and adequacy of selenium status: a review. Eur J Nutr 58:391-402
14. Finley J (2005) Selenium accumulation in plant foods. Nutr Rev 63:196-202
15. Food and Nutrition Board of the Institute of Medicine (2000) Dietary reference intakes for vitamin C, vitamin E, selenium and carotenoids. National Academy Press, Washington, DC
16. Stockler-Pinto MB, Mafra D, Farage NE et al (2010) Effect of Brazil nut supplementation on the blood levels of selenium and glutathione peroxidase in hemodialysis patients. Nutr 11:1065-1069
17. Stockler-Pinto MB, Lobo J, Moraes C et al (2012) Effect of Brazil nut supplementation on plasma levels of selenium in hemodialysis patients: 12 months of follow-up. J Renal Nutr 4:434-449
18. Fouque D, Vennegoor M, Ter Wee P et al (2007) EBPG guideline on nutrition. Nephrol Dial Transplant 22(Suppl 2):ii45-ii87
19. Ferreira KS, Gomes JC, Bellato CR et al (2002) Concentrações de selênio em alimentos consumidos no Brasil. Pan Am J Public Health 11:172-177 (Pubitemid 34450391)
20. Friedwald WT, Levi RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
21. Castelli WP, Abbott RD, Mcnamara PM (1983) Summary estimates of cholesterol used to predict coronary heart disease. Circulation 63: 730-734 (Pubitemid 13161449)
22. Ortuño J, Ros G, Periago MJ et al (1997) Nutritional importance of selenium. Arch Lat Am Nutr 47:1-13
23. Van Dael P, Deelstra H (1993) Selenium. Int J Vitam Nutr Res 63: 312-316
24. Zachara BA, Adamowicz A, Trafikowska U et al (2000) Decreased plasma glutathione peroxidase activity in uremic patients. Nephrol 84:278-279
25. Zachara BA, Trafikowska U, Adamowicz A et al (2001) Selenium, glutathione peroxidases, and somer other antioxidant parameters in blood of patients with chronic renal failure. J Trace Elem Med Biol 15:161-166 (Pubitemid 33150866)
26. Zachara BA, Salak A, Koterska D et al (2004) Selenium and glutathione peroxidases in blood of patients with different stages of chronic renal failure. J Trace Elem Med Biol 17:291-299 (Pubitemid 38520269)
27. Yang CY, Wu ML, Chou YY et al (2012) Essential trace element status and clinical outcomes in long-term dialysis patients: a two-year prospective observational cohort study. Clin Nutr 31:630-636
28. Koide S, Kinoshita Y, Ito N et al (2010) Determination of human serum 8-hydroxy-2′-deoxyguanosine (8-OHdG) by HPLC-ECD combined with solid phase extraction (SPE). J Chromatogr B Analyt Technol Biomed Life Sci 878:2163-2167
29. Valavanidis A, VlachogianniT FC (2009) 8-Hydroxy-2′-deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis. j Environ Sci Health, Part C: Environ Carcinog Ecotoxicol Rev 27:120-139
30. Tarng DC, Liu TY, Huang TP (2004) Protective effect of vitamin C on 8-hydroxy-2-deoxyguanosine level in peripheral blood lymphocytes of chronic hemodialysis patients. Kidney Int 66:820-831
31. Marstalerz-Migas A, Steciwko A, Pokorski M et al (2006) What influences the level of oxidative stress as measured by 8-hydroxy-2′-deoxyguanosine in patients on hemodialysis? J Physiol Pharmacol 57(Suppl 4):199-205 (Pubitemid 44638202)
32. Kaya Y, Ari E, Demir H et al (2012) Accelerated atherosclerosis in haemodialysis patients; correlation of endothelial function with oxidative DNA damage. Nephrol Dial Transplant 27:1164-1169
33. Zachara BA, Gromadzinska J, Palus J et al (2011) The effect of selenium supplementation in the prevention of DNA damage in white blood cells of hemodialyzed patients: a pilot study. Biol Trace Elem Res 142:274-283
34. Stopper H, Treutlein AT, Bahner U et al (2008) Reduction of the genomic damage level in haemodialysis patients by folic acid and vitamin B12 supplementation. Nephrol Dial Transplant 23:3272-3279
35. Schupp N, Schmid U, Heidland A et al (2008) New approaches for the treatment of genomic damage in end-stage renal disease. J Ren Nutr 18:127-133 (Pubitemid 350251841)
36. Grotto D, Barcelos GRM, Valentini J et al (2009) Low level of methylmercury induce DNA damage in rats: protective effects of selenium. Arch Toxicol 83:249-254
37. Handelman GJ, Walter MF, Adhikarla R et al (2011) Elevated plasma F2-isoprostanes in patients on long-term hemodialysis. Kidney Int 59:1960-1966
38. Johnson-Davis KL, Fernelius C, Eliason NB et al (2011) Blood enzymes and oxidative stress in chronic kidney disease: a cross sectional study. Ann Clin Lab Sci 41:331-339
39. Hsu SP, Chiang CK, Yang SY et al (2010) N-Acetylcysteine for the management of anemia and oxidative stress in hemodialysis patients. Nephron Clin Pract 116:207-216
40. Cominetti C, de Bortoloi M, Jr G et al (2012) Brazilian nut consumption improves selenium status and glutathione activity and reduces atherogenic risk in obese women. Nutr Res 32:403-407
41. Ingelsson E, Schaefer EJ, Contois JH et al (2007) Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA 298:776-785 (Pubitemid 47263160)
42. Fairweather-Tait SJ, Bao Y, Broadley MR et al (2011) Selenium in human health and disease. Antioxid Redox Signal 14:1337-1383
43. Pedruzzi LM, Stockler-Pinto MB, Leite M Jr et al (2012) Nrf2-keap1 system versus NF-kB: the good and the evil in chronic kidney disease? Biochimi 12:2461-2466
44. Cardozo LFMF, Preduzzi LM, Stockler-Pinto et al (2013) Effect of Brazilian nut supplementation on Nrf2 and NF-κB expression in hemodialysis patients. Annals of American Society of Nephrology, Kidney Week, 188p